• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The course of metastatic disease originating from carcinoma of the prostate.

作者信息

Plesnicar S

出版信息

Clin Exp Metastasis. 1985 Apr-Jun;3(2):103-10. doi: 10.1007/BF01758959.

DOI:10.1007/BF01758959
PMID:4042459
Abstract

The purpose of this work was to study the time sequence and the patterns of the multistep spread of metastases. Fifty-one patients with stage D carcinoma of the prostate, previously treated for their primary tumor by surgery or radiotherapy combined with hormonal manipulation and for metastases by hormones and chemotherapy, were included in the study. The metastatic dissemination, characterized primarily by the appearance of bone metastases, could follow two distinct patterns: The first, characterized by sequential appearance of osteoblastic metastases, followed by the development of osteolytic bone lesions, and the second pattern, characterized by the simultaneous appearance of osteoblastic and osteolytic bone lesions. In cases with solely osteoblastic bone metastases, the lesions are hormone sensitive and long-lasting remissions could be obtained. The development of osteolytic bone lesions is usually accompanied by the recurrence of the primary tumor and appearance of metastases in other sites, such as the lymph nodes and lungs. Bone metastases became resistant to hormonal manipulation and with chemotherapy short remissions were obtained. The course of the terminal period is faster, with shorter survival times. The determination of serum acid and alkaline phosphatase levels seems to reflect the course of the disease during the initial period of the disease only, i.e. when bone metastases are sensitive to hormonal treatment.

摘要

相似文献

1
The course of metastatic disease originating from carcinoma of the prostate.
Clin Exp Metastasis. 1985 Apr-Jun;3(2):103-10. doi: 10.1007/BF01758959.
2
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
3
Osteoblastic flare assessed by serum alkaline phosphatase activity is an index of short duration of response in prostate cancer patients with bone metastases submitted to systemic therapy.Gruppo Onco Urologico Piemontese (G.O.U.P).通过血清碱性磷酸酶活性评估的成骨细胞耀斑是接受全身治疗的前列腺癌骨转移患者短期反应的一个指标。皮埃蒙特肿瘤泌尿学组(G.O.U.P)。
Anticancer Res. 1997 Nov-Dec;17(6D):4697-702.
4
[Is skeletal alkaline phosphatase a valid staging marker in detection of osteoblastic skeletal metastases of prostate carcinoma?].[骨碱性磷酸酶在前列腺癌成骨性骨转移检测中是有效的分期标志物吗?]
Z Orthop Ihre Grenzgeb. 1998 May-Jun;136(3):255-9. doi: 10.1055/s-2008-1054232.
5
Renal tubular reabsorption of phosphate is positively related to the extent of bone metastatic load in patients with prostate cancer.前列腺癌患者肾小管对磷酸盐的重吸收与骨转移负荷程度呈正相关。
J Clin Endocrinol Metab. 1998 May;83(5):1535-41. doi: 10.1210/jcem.83.5.4757.
6
[Serum alkaline phosphatase flare in prostate cancer accompanied by bone metastases and treated with hormonal therapy. TEKK Study Group].[伴有骨转移并接受激素治疗的前列腺癌患者血清碱性磷酸酶激增。TEKK研究组]
Hinyokika Kiyo. 1999 Oct;45(10):681-5.
7
Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model.在严重联合免疫缺陷小鼠模型中使用唑来膦酸治疗成骨细胞性病变与溶骨性病变。
Cancer Res. 2002 Oct 1;62(19):5564-70.
8
[Measurement of skeletal alkaline phosphatase in prostatic carcinoma. Preliminary report].
Minerva Urol Nefrol. 1995 Mar;47(1):9-12.
9
Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.联合使用抗酒石酸酸性磷酸酶、碱性磷酸酶和前列腺特异性抗原预测前列腺癌患者的骨转移
Int J Urol. 2008 May;15(5):419-22. doi: 10.1111/j.1442-2042.2008.02029.x.
10
Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment.前列腺癌来源的前列腺酸性磷酸酶促进骨微环境中的成骨反应。
Clin Exp Metastasis. 2014 Feb;31(2):247-56. doi: 10.1007/s10585-013-9625-2. Epub 2013 Nov 17.

引用本文的文献

1
Extraconal Orbital Soft Tissue Metastasis Secondary to Prostate Cancer: An Unusual Presentation.前列腺癌继发眶外软组织转移:一种罕见的表现。
World J Oncol. 2014 Jun;5(3):139-143. doi: 10.14740/wjon807w. Epub 2014 Jun 25.
2
A 73-year-old man with congestion and mild proptosis of the left eye.一名73岁男性,左眼充血伴轻度眼球突出。
Digit J Ophthalmol. 2016 Apr 25;22(2):58-61. doi: 10.5693/djo.03.2014.05.001. eCollection 2016.
3
Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation.

本文引用的文献

1
The spread of prostatic carcinoma to the bones.前列腺癌向骨骼的扩散。
J Pathol Bacteriol. 1953 Jul;66(1):91-3. doi: 10.1002/path.1700660112.
2
The dedifferentiation of prostate carcinoma.前列腺癌的去分化
Cancer. 1983 Jul 15;52(2):246-51. doi: 10.1002/1097-0142(19830715)52:2<246::aid-cncr2820520210>3.0.co;2-q.
3
Prognosis in patients with carcinoma of the prostate.前列腺癌患者的预后
多臂树枝状高分子 PHSCN 增强抑制人前列腺癌细胞浸润、转移和肺集落形成的能力。
Clin Exp Metastasis. 2010 Mar;27(3):173-84. doi: 10.1007/s10585-010-9316-1. Epub 2010 Mar 26.
4
Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma.p501s(prostein)在检测转移性前列腺腺癌方面与前列腺特异性抗原(PSA)的诊断效用比较。
Diagn Pathol. 2007 Oct 27;2:41. doi: 10.1186/1746-1596-2-41.
5
Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the alpha 2 beta 1 integrin.骨细胞基质通过α2β1整合素促进人前列腺癌细胞的黏附。
Clin Exp Metastasis. 1996 Jan;14(1):19-26. doi: 10.1007/BF00157682.
6
A quantitative model for spontaneous bone metastasis: evidence for a mitogenic effect of bone on Walker 256 cancer cells.
Clin Exp Metastasis. 1992 Nov;10(6):403-10. doi: 10.1007/BF00133469.
Cancer. 1970 Apr;25(4):911-8. doi: 10.1002/1097-0142(197004)25:4<911::aid-cncr2820250426>3.0.co;2-y.
4
Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.联合组织学分级和临床分期预测前列腺腺癌的预后
J Urol. 1974 Jan;111(1):58-64. doi: 10.1016/s0022-5347(17)59889-4.
5
Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate.
Cancer. 1973 Nov;32(5):1126-30. doi: 10.1002/1097-0142(197311)32:5<1126::aid-cncr2820320518>3.0.co;2-c.
6
[Extraosseous metastases of carcinoma of the prostate (author's transl)].前列腺癌的骨外转移(作者译)
Dtsch Med Wochenschr. 1974 Oct 25;99(43):2148-50, 55-6. doi: 10.1055/s-0028-1108102.
7
Prostatic carcinoma: the relationship between histologic grade and incidence of early metastases.前列腺癌:组织学分级与早期转移发生率之间的关系。
J Urol. 1972 Dec;108(6):905-7. doi: 10.1016/s0022-5347(17)60903-0.
8
The metastatic spread of kidney and prostate cancers in man.人类肾癌和前列腺癌的转移扩散
Neoplasma. 1976;23(3):323-32.
9
Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation.血清前列腺酸性磷酸酶的免疫化学检测。方法与临床评估。
Invest Urol. 1978 Jan;15(4):319-23.